Literature DB >> 9204983

Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?

R Pawson1, E Matutes, V Brito-Babapulle, H Maljaie, M Hedges, J Mercieca, M Dyer, D Catovsky.   

Abstract

We report the clinical, ultrastructural, immunophenotypic and virological features of nine cases of a rare type of mature T cell disorder formerly designated Sezary cell leukaemia. All patients presented with lymphocytosis ranging from 12.7 to 133 x 10(9)/l, bone marrow infiltration, splenomegaly and lymphadenopathy. Skin involvement was absent at presentation but developed as a terminal event in two patients, one of whom showed a pattern of dermal infiltration different from that characteristic of Sezary syndrome. Cells from eight cases bore a mature T cell phenotype and electronmicroscopy revealed lymphocytes with cerebriform nuclei resembling Sezary cells. All cases except one were HTLV-I negative. Patients were treated with various chemotherapy regimens but with poor outcome, the median survival being 13 months. Laboratory and clinical data suggest great similarity between Sezary cell leukaemia and T prolymphocytic leukaemia (T-PLL), namely coexpression of CD4 and CD8 (3/9 cases), identical chromosomal abnormalities in the three cases studied (isochromosome 8q plus inversion 14 or t(X;14)(q28;q11)) and a remarkable sensitivity to CAMPATH-1H (complete remission of 21 months' duration in one patient), suggesting that this entity could be considered a variant form of T-PLL. The alternative diagnosis of adult T cell leukaemia/lymphoma could not be excluded in one patient in whom positive HTLV-I serology was documented.

Entities:  

Mesh:

Year:  1997        PMID: 9204983     DOI: 10.1038/sj.leu.2400710

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  4 in total

1.  T-cell prolymphocytic leukemia.

Authors:  Robbie L Graham; Barry Cooper; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-01

2.  Cerebriform variant type of T cell prolymphocytic leukemia with complex karyotype including an additional segment at 1p36.1.

Authors:  Senji Kasahara; Hisashi Tsurumi; Yuhei Shibata; Takuro Matsumoto; Nobuhiko Nakamura; Hiroshi Nakamura; Nobuhiro Kanemura; Naoe Goto; Takeshi Hara; Hisataka Moriwaki
Journal:  Int J Hematol       Date:  2012-10-05       Impact factor: 2.490

3.  A personal history of the CAMPATH-1H antibody.

Authors:  Herman Waldmann
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

Review 4.  Advances in the understanding and management of T-cell prolymphocytic leukemia.

Authors:  Kamel Laribi; Pierre Lemaire; Jeremy Sandrini; Alix Baugier de Materre
Journal:  Oncotarget       Date:  2017-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.